Biopharmaceutical benchmarks—2003
- 1 August 2003
- journal article
- Published by Springer Nature in Nature Biotechnology
- Vol. 21 (8) , 865-870
- https://doi.org/10.1038/nbt0803-865
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Cancer risk prompts US to curb gene therapyNature, 2003
- Tissue engineering firms go underNature Biotechnology, 2002
- Gene Therapy: Promises and ProblemsAnnual Review of Genomics and Human Genetics, 2001
- Key issues in non-viral gene delivery1PII of original article: S0169-409X(98)00048-9. The article was originally published in Advanced Drug Delivery Reviews 34 (1998) 3–19.1Advanced Drug Delivery Reviews, 2001
- The delivery of antisense therapeuticsAdvanced Drug Delivery Reviews, 2000
- Biopharmaceutical benchmarksNature Biotechnology, 2000
- Synthetic DNA delivery systemsNature Biotechnology, 2000
- Human Gene Therapy Harsh Lessons, High HopesFDA Consumer, 2000